You are here

  • Home
  • Archive
  • Volume 71, Issue 5
  • HER2 testing of gastro-oesophageal adenocarcinoma: a commentary and guidance document from the Association of Clinical Pathologists Molecular Pathology and Diagnostics Committee

Article metrics

Article menu
Download PDFPDF
Best practice
HER2 testing of gastro-oesophageal adenocarcinoma: a commentary and guidance document from the Association of Clinical Pathologists Molecular Pathology and Diagnostics Committee

 

Online download statistics by month:

Online download statistics by month: February 2018 to March 2024

AbstractFullPdf
Feb 20185544940
Mar 20182263415
Apr 20185386451
May 20185067565
Jun 20183494835
Jul 20182343822
Aug 20181711727
Sep 20181801413
Oct 20181522826
Nov 20181611517
Dec 20181392421
Jan 20191152214
Feb 201910654
Mar 201910399
Apr 20198966
May 2019971411
Jun 201964149
Jul 20197569
Aug 20191401513
Sep 201910694
Oct 20198698
Nov 20197185
Dec 20199696
Jan 202086157
Feb 2020762011
Mar 20206686
Apr 20206876
May 20209888
Jun 20207985
Jul 20209133
Aug 202065115
Sep 20209145
Oct 20205164
Nov 20206966
Dec 20206086
Jan 20218954
Feb 20215654
Mar 20211171011
Apr 20216073
May 20213465
Jun 20211084
Jul 2021877
Aug 20211266
Sep 2021985
Oct 20216741
Nov 202167135
Dec 20218775
Jan 20227363
Feb 2022114196
Mar 20227195
Apr 20221121623
May 2022121166
Jun 2022118103
Jul 202281114
Aug 202213890
Sep 202297122
Oct 2022129142
Nov 2022103141
Dec 202214960
Jan 20235791
Feb 2023100115
Mar 2023136102
Apr 202334102
May 20236340
Jun 20238051
Jul 20234040
Aug 202390123
Sep 2023102171
Oct 202371222
Nov 202389102
Dec 202391283
Jan 20245423
Feb 202413767
Mar 20247233
Total83961017652